58 results
8-K
EX-1.1
NUVL
Nuvalent, Inc.
17 Sep 24
Nuvalent Announces Pricing of Upsized Public Offering of Common Stock
4:21pm
304 and 305 of ERISA); (v) the fair market value of the assets of each Plan exceeds the present value of all benefits accrued under such Plan … the relative benefits received by the Company, on the one hand, and the Underwriters on the other, from the offering of the Shares or (ii) if the allocation
424B5
NUVL
Nuvalent, Inc.
17 Sep 24
Prospectus supplement for primary offering
4:13pm
responses. This may result in the potential to drive deeper, more durable responses with minimal adverse events, and we believe these potential benefits … applicable certification and other requirements. Non-U.S. holders are urged to consult their tax advisors regarding their entitlement to benefits
424B5
NUVL
Nuvalent, Inc.
16 Sep 24
Prospectus supplement for primary offering
7:16am
result in the potential to drive deeper, more durable responses with minimal adverse events, and we believe these potential benefits may support … . Non-U.S. holders are urged to consult their tax advisors regarding their entitlement to benefits under a relevant income tax treaty.
A non-U.S
8-K
EX-99.1
8t3835 r1bwi9t0t80ht
9 May 24
Nuvalent Highlights Pipeline Progress, Reiterates Key Anticipated Milestones, and Reports First Quarter 2024 Financial Results
6:37am
8-K
EX-99.1
1e5ety o7bcv83xyb
27 Feb 24
Nuvalent Highlights Pipeline Progress, Reiterates Key Anticipated Milestones and Reports Fourth Quarter and Full Year 2023 Financial Results
6:38am
8-K
EX-99.1
bfqrs pgo
9 Jan 24
Nuvalent Announces “OnTarget 2026” Operating Plan and Key Anticipated Milestones
4:40pm
8-K
EX-99.1
tdaxcnsj0c19
14 Nov 23
Nuvalent Highlights Corporate and Pipeline Achievements and Reports Third Quarter
6:45am
8-K
EX-1.1
o1s9e65m3968g o269
17 Oct 23
Nuvalent Announces Pricing of Public Offering of Common Stock
4:07pm
424B5
bafg ldxtxn4xdmu8
17 Oct 23
Prospectus supplement for primary offering
4:05pm
424B5
83nwpvq4u7d9vyl5ghbk
16 Oct 23
Prospectus supplement for primary offering
7:39am
8-K
EX-99.1
wts 9twm6
10 Aug 23
Nuvalent Highlights Pipeline Progress and Reports Second Quarter 2023 Financial Results
6:45am
8-K
EX-99.1
c1z zyvd6a6
11 May 23
Nuvalent Announces Anticipated Timing of Preliminary Phase 1 Dose-Escalation Data for NVL-655 and Reports First Quarter 2023 Financial Results
6:39am